Cargando…
A dynamic transcriptomic atlas of cytokine-induced killer cells
Several clinical immunotherapy trials with cytokine-induced killer (CIK) cells have been reported. However, molecular evidence of cell expansion, acquisition of tumor cytotoxicity, and safety of CIK cells is required before putting them to clinical use. Here, we performed dynamic transcriptomic anal...
Autores principales: | Meng, Mingyao, Li, Lin, Li, Ruhong, Wang, Wenju, Chen, Yang, Xie, Yanhua, Han, Rui, Zhu, Kai, Huang, Wenwen, Yang, Lili, Li, Shuo, Shi, Jianlin, Tan, Weiwei, Gao, Hui, Zhao, Yiyi, Yang, Li, Tan, Jing, Hou, Zongliu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314136/ https://www.ncbi.nlm.nih.gov/pubmed/30333226 http://dx.doi.org/10.1074/jbc.RA118.003280 |
Ejemplares similares
-
Retrospective analysis of the efficacy of adjuvant cytokine‐induced killer cell immunotherapy combined with chemotherapy in colorectal cancer patients after surgery
por: Li, Xiao, et al.
Publicado: (2022) -
MicroRNA profiling of CD3(+)CD56(+) cytokine-induced killer cells
por: Wang, Wenju, et al.
Publicado: (2015) -
Impact of cytotoxic T lymphocytes immunotherapy on prognosis of colorectal cancer patients
por: Zhu, Yankun, et al.
Publicado: (2023) -
Global transcriptome-wide analysis of CIK cells identify distinct roles of IL-2 and IL-15 in acquisition of cytotoxic capacity against tumor
por: Wang, Wenju, et al.
Publicado: (2014) -
OLFM4 depletion sensitizes gallbladder cancer cells to cisplatin through the ARL6IP1/caspase-3 axis
por: Lin, Zhuying, et al.
Publicado: (2021)